Adverse events · people living in malaria‐endemic areas
It is very uncertain whether ivermectin changes adverse events compared with control (very low certainty).
1 finding from 1 review
RR 1.63 [1, 2.67]
2712 participants
Very low
Intervention not reported
Adverse events · people residing in communities endemic for onchocerciasis
The intervention probably leads to lower adverse events (moderate certainty).
1 finding from 1 review
no estimate extracted
2010 participants
Moderate
Intervention not reported
Adverse events report of adverse events · patients with treating strongyloides infection
The intervention showed no clear difference in adverse events report of adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events report of adverse events · patients with treating strongyloides infection
The intervention probably leads to lower adverse events report of adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Any adverse events during the trial period · all trials contributing results to the summary of findings table included people with mild disease (WHO scale 1 to 3)§
The intervention showed no clear difference in any adverse events during the trial period (low certainty).
1 finding from 1 review
Intervention not reported
Any adverse events during the trial period · people with moderate to severe disease (WHO scale 4–9); all trials contributing results to the summary of findings table investigated…
The intervention showed no clear difference in any adverse events during the trial period (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events during the trial period · all trials contributing results to the summary of findings table included people with mild disease (WHO scale 1 to 3)§
The intervention showed no clear difference in serious adverse events during the trial period (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events during the trial period · people with moderate to severe disease (WHO scale 4–9); all trials contributing results to the summary of findings table investigated…
It is very uncertain whether the intervention changes serious adverse events during the trial period (very low certainty).
1 finding from 1 review